59382-60-4

Usage

Uses

Used in Fragrance Industry:
Ethyl 2-methyl-3-nitrobenzoate is used as a fragrance ingredient for its ability to impart a distinct and pleasant scent to various products. It is commonly used in the manufacturing of perfumes, contributing to their unique and appealing aroma.
Used in Food Industry:
In the food industry, Ethyl 2-methyl-3-nitrobenzoate is used as a flavoring agent to enhance the taste and aroma of various food products. Its use in food products is carefully regulated to ensure safety and quality.
Used in Pharmaceutical Industry:
Ethyl 2-methyl-3-nitrobenzoate is used as a source of 2-methyl-3-nitrobenzoic acid in organic synthesis, which serves as a building block for the development of various pharmaceuticals. Its role in the synthesis of active pharmaceutical ingredients makes it an important compound in the pharmaceutical industry.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, Ethyl 2-methyl-3-nitrobenzoate is utilized as a precursor for the synthesis of agrochemicals. Its contribution to the development of effective and safe agrochemicals is significant.
However, it is crucial to handle Ethyl 2-methyl-3-nitrobenzoate with caution due to its toxic nature. Ingestion, inhalation, or skin contact with Ethyl 2-methyl-3-nitrobenzoate can lead to adverse health effects. Proper safety measures and handling protocols should be followed to minimize risks associated with its use.

Upstream product

• 64-17-5 ethanol 
• 1975-50-4 2-methyl-3-nitrobenzic acid 

Downstream Products

• 71516-34-2 2-((E)-2-Dimethylamino-vinyl)-3-nitro-benzoic acid ethyl ester 
• 98664-90-5 ethyl (6aRS,9SR,9aSR)-hexahydro-7,7-dimethylisoindolo[4,5,6-cd]indole-9-carboxylate 
• 50614-84-1 ethyl indole-4-carboxylate 
• 1074-85-7 (1H-indol-4-yl)methanol 
• 862297-56-1 4-[(tert-butyldiphenylsilyloxy)methyl]-1-(4-toluenesulfonyl)indole-3-carboxaldehyde 
• 862297-63-0 ethyl 2-azido-5-methyl-3-{4-[(tert-butyldiphenylsilyloxy)methyl]-1-(4-toluenesulfonyl)-indol-3-yl}-hex-4-enoate 
• 862297-62-9 ethyl 5-methyl-3-{[4-(tert-butyldiphenylsilyloxy)methyl]-1-(4-toluenesulfonyl)indol-3-yl}hex-4-enoate 
• 862297-61-8 4-[(tert-butyldiphenylsilyloxy)methyl]indole-3-carboxaldehyde 
• 862297-60-7 4-[(tert-butyldiphenylsilyloxy)methyl]indole 
• 57414-85-4 ethyl 3-amino-2-methyl-benzoate 
• 138334-85-7 2-[2-(2-Ethoxycarbonyl-6-nitro-phenyl)-1-(4-methoxy-phenyl)-ethyl]-malonic acid dimethyl ester 
• 142314-71-4 ethyl 2-bromomethyl-3-nitrobenzoate 
• 138334-49-3 (3S,4R)-3-Acetoxy-1-(2-dimethylamino-ethyl)-4-(4-methoxy-phenyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-6-carboxylic acid ethyl ester 
• 138335-02-1 (3R,4S)-3-Hydroxy-4-(4-methoxy-phenyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-6-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Synthesis of symmetric diester-functionalised Troeger's base analogues

The yields of ester-functionalised Troeger's base analogues are dramatically improved by incorporating an electron-donating group on the aromatic ring and/or enhancing solubil- ity of the aniline unit. In addition to 2,8-diester compounds, 1,7-, 3,9- and 4,10-diester-functionalised Troeger's base analogues have been prepared for the first time.

ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES

Disclosed is a compound of Formula (I) in which W and R1-R6 are defined herein. Also disclosed is a method of treating spinal muscular atrophy, as well as methods of using such compounds to increase SMN expression, increase EAAT2 expression, or increase the expression of a nucleic acid that encodes a translational stop codon introduced directly or indirectly by mutation or frameshift.